444 related articles for article (PubMed ID: 29112898)
21. Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
Verweij-van Wissen CP; de Graaff-Teulen MJ; de Kanter CT; Aarnoutse RE; Burger DM
Ther Drug Monit; 2015 Oct; 37(5):626-33. PubMed ID: 25627404
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of brinzolamide in dried blood spots by a novel LC-QTOF-MS/MS method.
Foivas A; Malenović A; Kostić N; Božić M; Knežević M; Loukas YL; Dotsikas Y
J Pharm Biomed Anal; 2016 Feb; 119():84-90. PubMed ID: 26669612
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots.
Baietto L; D'Avolio A; Ariaudo A; Corcione S; Simiele M; Cusato J; Urbino R; Di Perri G; Ranieri VM; De Rosa FG
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():42-7. PubMed ID: 23973533
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.
Hinchliffe E; Adaway JE; Keevil BG
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():102-7. PubMed ID: 21680259
[TBL] [Abstract][Full Text] [Related]
25. Fully automated therapeutic drug monitoring of anti-epileptic drugs making use of dried blood spots.
Velghe S; Deprez S; Stove CP
J Chromatogr A; 2019 Sep; 1601():95-103. PubMed ID: 31208795
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card And Prep DBS System.
Ganz N; Singrasa M; Nicolas L; Gutierrez M; Dingemanse J; Döbelin W; Glinski M
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():50-60. PubMed ID: 22227055
[TBL] [Abstract][Full Text] [Related]
28. Validation and clinical application of an LC-MS/MS method for the quantification of everolimus using volumetric absorptive microsampling.
Verheijen RB; Thijssen B; Atrafi F; Schellens JHM; Rosing H; de Vries N; Beijnen JH; Mathijssen RHJ; Steeghs N; Huitema ADR
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():234-239. PubMed ID: 30530116
[TBL] [Abstract][Full Text] [Related]
29. Haematocrit corrected analysis of creatinine in dried blood spots through potassium measurement.
den Burger JC; Wilhelm AJ; Chahbouni AC; Vos RM; Sinjewel A; Swart EL
Anal Bioanal Chem; 2015 Jan; 407(2):621-7. PubMed ID: 25374126
[TBL] [Abstract][Full Text] [Related]
30. Fully Automated Dried Blood Spot Extraction coupled to Liquid Chromatography-tandem Mass Spectrometry for Therapeutic Drug Monitoring of Immunosuppressants.
Deprez S; Stove CP
J Chromatogr A; 2021 Sep; 1653():462430. PubMed ID: 34384960
[TBL] [Abstract][Full Text] [Related]
31. A validated method for the quantification of fosfomycin on dried plasma spots by HPLC-MS/MS: application to a pilot pharmacokinetic study in humans.
Parker SL; Lipman J; Dimopoulos G; Roberts JA; Wallis SC
J Pharm Biomed Anal; 2015 Nov; 115():509-14. PubMed ID: 26299527
[TBL] [Abstract][Full Text] [Related]
32. Estimation and Correction of the Blood Volume Variations of Dried Blood Spots Using a Postcolumn Infused-Internal Standard Strategy with LC-Electrospray Ionization-MS.
Liao HW; Lin SW; Chen GY; Kuo CH
Anal Chem; 2016 Jun; 88(12):6457-64. PubMed ID: 27216241
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of an LC-MS/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system.
Duthaler U; Suenderhauf C; Gaugler S; Vetter B; Krähenbühl S; Hammann F
J Pharm Biomed Anal; 2019 Aug; 172():18-25. PubMed ID: 31015095
[TBL] [Abstract][Full Text] [Related]
34. Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence.
Lawson G; Cocks E; Tanna S
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():72-9. PubMed ID: 22552005
[TBL] [Abstract][Full Text] [Related]
35. A dried blood spot assay with UPLC-MS/MS for the simultaneous determination of E6005, a phosphodiesterase 4 inhibitor, and its metabolite in human blood.
Kita K; Ishii T; Hotta K; Mano Y
J Pharm Biomed Anal; 2018 Aug; 157():208-216. PubMed ID: 29803912
[TBL] [Abstract][Full Text] [Related]
36. Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer® qDBS device.
Deprez S; Van Uytfanghe K; Stove CP
Anal Chim Acta; 2023 Feb; 1242():340797. PubMed ID: 36657891
[TBL] [Abstract][Full Text] [Related]
37. Analysis of ochratoxin A in dried blood spots - Correlation between venous and finger-prick blood, the influence of hematocrit and spotted volume.
Osteresch B; Cramer B; Humpf HU
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():158-64. PubMed ID: 27046696
[TBL] [Abstract][Full Text] [Related]
38. Application of non-contact hematocrit prediction technologies to overcome hematocrit effects on immunosuppressant quantification from dried blood spots.
Deprez S; Heughebaert L; Boffel L; Stove CP
Talanta; 2023 Mar; 254():124111. PubMed ID: 36462285
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a liquid chromatography/tandem mass spectrometry method for determination of caspofungin in dried blood spots.
Cheng X; Liu K; Liu Y; Wang M; Ma Y
Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1068-1074. PubMed ID: 29504640
[TBL] [Abstract][Full Text] [Related]
40. A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma.
Venkatesh B; Yuile A; McKay MJ; Narayanan S; Wheeler H; Itchins M; Pavlakis N; Clarke SJ; Molloy MP
Ther Drug Monit; 2024 Jun; 46(3):332-343. PubMed ID: 38263583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
